Geode Capital Management LLC Has $2.13 Million Holdings in Aemetis, Inc. (NASDAQ:AMTX)

Geode Capital Management LLC raised its holdings in Aemetis, Inc. (NASDAQ:AMTX) by 7.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 924,293 shares of the specialty chemicals company’s stock after buying an additional 66,031 shares during the period. Geode Capital Management LLC owned about 1.86% of Aemetis worth $2,126,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. FMR LLC lifted its holdings in Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares during the last quarter. Hutchinson Capital Management CA bought a new position in shares of Aemetis in the second quarter valued at about $70,000. Barclays PLC lifted its stake in shares of Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after buying an additional 34,816 shares during the last quarter. Rhumbline Advisers boosted its holdings in shares of Aemetis by 2,837.1% during the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after buying an additional 50,528 shares during the period. Finally, Wellington Management Group LLP acquired a new position in Aemetis in the 3rd quarter valued at about $177,000. 27.02% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have issued reports on AMTX shares. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research report on Friday, January 3rd. HC Wainwright restated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research note on Monday, December 23rd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $12.95.

Aemetis Trading Down 3.0 %

NASDAQ AMTX opened at $2.90 on Wednesday. The company has a market cap of $144.23 million, a price-to-earnings ratio of -1.28 and a beta of 1.47. The company has a 50 day moving average of $3.27 and a 200-day moving average of $2.97. Aemetis, Inc. has a 1-year low of $2.10 and a 1-year high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same period in the prior year, the firm earned ($0.59) earnings per share. On average, equities research analysts forecast that Aemetis, Inc. will post -2.02 earnings per share for the current year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.